Request Demo
Last update 08 Jul 2025
Cellgram-ED
Last update 08 Jul 2025
Overview
Basic Info
Drug Type Stem cell therapy |
Synonyms Cellgram |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (23 Dec 2011), |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Cellgram-EDNCT04594850
An Single-blind, Multi-center, Randomization, Phase Ⅱ Study to Evaluate Efficacy and Safety of Cellgram-ED (Autologous Bone Marrow-derived Mesenchymal Stem Cells) in Erectile Dysfunction Patients With Following Radical Prostatectomy
JPRN-jRCT2013190010
Intravenous infusion of autologous mesenchymal stem cells (MSC) from bone marrow for Amyotrophic lateral sclerosis (ALS) patients: double-blind randomized controlled trial - STR01-09
NCT01676441
A Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Patients With Chronic Spinal Cord Injury.
100 Clinical Results associated with Cellgram-ED
Login to view more data
100 Translational Medicine associated with Cellgram-ED
Login to view more data
100 Patents (Medical) associated with Cellgram-ED
Login to view more data
100 Deals associated with Cellgram-ED
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Myocardial Infarction | South Korea | 23 Dec 2011 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Liver Cirrhosis | Phase 3 | South Korea | 26 Feb 2021 | |
| Spinal Cord Injuries | Phase 3 | United States | 01 Aug 2008 | |
| Stroke | Phase 3 | South Korea | 24 Jan 2008 | |
| Erectile Dysfunction | Phase 2 | United States | 19 Oct 2020 | |
| Respiratory Distress Syndrome, Adult | Phase 2 | South Korea | 25 Jan 2014 | |
| Renal transplant rejection | Phase 2 | South Korea | 07 Dec 2007 | |
| Parkinson Disease | Phase 2 | South Korea | 29 Dec 2006 | |
| Brain Injuries | Clinical | South Korea | - | |
| Cerebral Hemorrhage | Clinical | South Korea | - | |
| Solid tumor | Clinical | South Korea | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free